Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Characterization of the microheterogeneity of transthyretin in plasma and urine using SELDI-TOF-MS immunoassay.
Schweigert FJ, Wirth K, Raila J.
Proteome Sci. 2004 Sep 1;2(1):5.
Related citations
Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients.
Gericke B, Raila J, Sehouli J, Haebel S, Könsgen D, Mustea A, Schweigert FJ.
BMC Cancer. 2005 Oct 17;5:133.
Characterization of transthyretin variants in familial transthyretin amyloidosis by mass spectrometric peptide mapping and DNA sequence analysis.
Lim A, Prokaeva T, McComb ME, O'Connor PB, Théberge R, Connors LH, Skinner M, Costello CE.
Anal Chem. 2002 Feb 15;74(4):741-51.
Identification of S-sulfonation and S-thiolation of a novel transthyretin Phe33Cys variant from a patient diagnosed with familial transthyretin amyloidosis.
Lim A, Prokaeva T, McComb ME, Connors LH, Skinner M, Costello CE.
Protein Sci. 2003 Aug;12(8):1775-85.
High-throughput protein characterization using mass spectrometric immunoassay.
Kiernan UA, Tubbs KA, Gruber K, Nedelkov D, Niederkofler EE, Williams P, Nelson RW.
Anal Biochem. 2002 Feb 1;301(1):49-56.
Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D, Howard JC, Varallo VM, Cadieux P, Bowley E, McLean K, Pak BJ, Gan BS.
Clin Invest Med. 2006 Jun;29(3):136-45.
Alteration of transthyretin microheterogeneity in serum of multiple trauma patients.
Gericke B, Raila J, Deja M, Rohn S, Donaubauer B, Nagl B, Haebel S, Schweigert FJ, Kaisers U.
Biomark Insights. 2007 Aug 8;2:299-306.
Quantification of fragments of human serum inter-alpha-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay.
Song J, Patel M, Rosenzweig CN, Chan-Li Y, Sokoll LJ, Fung ET, Choi-Miura NH, Goggins M, Chan DW, Zhang Z.
Clin Chem. 2006 Jun;52(6):1045-53. Epub 2006 Mar 30.
SELDI-TOF mass spectrometry evaluation of variant transthyretins for diagnosis and pathogenesis of familial amyloidotic polyneuropathy.
Ueda M, Misumi Y, Mizuguchi M, Nakamura M, Yamashita T, Sekijima Y, Ota K, Shinriki S, Jono H, Ikeda S, Suhr OB, Ando Y.
Clin Chem. 2009 Jun;55(6):1223-7. Epub 2009 Apr 16.
[Application to transthyretin analysis].
Ueda M, Ando Y.
Rinsho Byori. 2006 Jun;54(6):601-8. Japanese.
Detection of genetic variants of transthyretin by liquid chromatography-dual electrospray ionization fourier-transform ion-cyclotron-resonance mass spectrometry.
Nepomuceno AI, Mason CJ, Muddiman DC, Bergen HR 3rd, Zeldenrust SR.
Clin Chem. 2004 Sep;50(9):1535-43. Epub 2004 Jun 17.
Identification of transthyretin variants by sequential proteomic and genomic analysis.
Bergen HR 3rd, Zeldenrust SR, Butz ML, Snow DS, Dyck PJ, Dyck PJ, Klein CJ, O'Brien JF, Thibodeau SN, Muddiman DC.
Clin Chem. 2004 Sep;50(9):1544-52. Epub 2004 Jun 24.
Factors that influence retinol-binding protein 4-transthyretin interaction are not altered in overweight subjects and overweight subjects with type 2 diabetes mellitus.
Frey SK, Spranger J, Henze A, Pfeiffer AF, Schweigert FJ, Raila J.
Metabolism. 2009 Oct;58(10):1386-92. Epub 2009 Jun 18.
SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer.
Skytt A, Thysell E, Stattin P, Stenman UH, Antti H, Wikström P.
Int J Cancer. 2007 Aug 1;121(3):615-20.
[Plasma analysis of rheumatoid arthritis by SELDI].
Naishiro Y, Suzuki C, Kimura M, Yamamoto M, Takahashi H, Sohma H, Hori T, Shinomura Y, Kokai Y, Imai K.
Nihon Rinsho Meneki Gakkai Kaishi. 2007 Jun;30(3):145-50. Review. Japanese.
Proteomic distinction between humans and great apes based on plasma transthyretin microheterogeneity.
Schweigert FJ, Gerike B, Raila J, Haebel S, Eulenberger K.
Comp Biochem Physiol Part D Genomics Proteomics. 2007 Jun;2(2):144-9. Epub 2007 Feb 11.
Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF.
Rüetschi U, Zetterberg H, Podust VN, Gottfries J, Li S, Hviid Simonsen A, McGuire J, Karlsson M, Rymo L, Davies H, Minthon L, Blennow K.
Exp Neurol. 2005 Dec;196(2):273-81. Epub 2005 Sep 8.
Characterisation of protein microheterogeneity and protein complexes using on-chip immunoaffinity purification-mass spectrometry.
Schweigert FJ.
Brief Funct Genomic Proteomic. 2005 May;4(1):7-15. Review.
Post-translational modification of transthyretin in plasma.
Terazaki H, Ando Y, Suhr O, Ohlsson PI, Obayashi K, Yamashita T, Yoshimatsu S, Suga M, Uchino M, Ando M.
Biochem Biophys Res Commun. 1998 Aug 10;249(1):26-30.
Serum levels of variants of transthyretin down-regulation in cholangiocarcinoma.
Liu L, Wang J, Liu B, Dai S, Wang X, Chen J, Huang L, Xiao X, He D.
J Cell Biochem. 2008 Jun 1;104(3):745-55.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on